HEADER TRANSFERASE/INHIBITOR 31-AUG-23 8U1F TITLE FGFR2 KINASE DOMAIN BOUND TO IRREVERSIBLE INHIBITOR CMPD 10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FGFR-2,K-SAM,KGFR,KERATINOCYTE GROWTH FACTOR RECEPTOR; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR2, BEK, KGFR, KSAM; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR KINASE, ONCOPROTEIN, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.VALVERDE,L.FOSTER REVDAT 1 14-FEB-24 8U1F 0 JRNL AUTH H.SCHONHERR,P.AYAZ,A.M.TAYLOR,J.B.CASALETTO,B.B.TOURE, JRNL AUTH 2 D.T.MOUSTAKAS,B.M.HUDSON,R.VALVERDE,S.ZHAO,P.J.O'HEARN, JRNL AUTH 3 L.FOSTER,D.A.SHARON,S.GARFINKLE,F.GIORDANETTO,A.LESCARBEAU, JRNL AUTH 4 R.KURUKULASURIYA,N.GERAMI-MOAYED,D.MAGLIC,K.BRUDEREK,G.NAIK, JRNL AUTH 5 H.GUNAYDIN,M.M.MADER,A.A.BOEZIO,T.H.MCLEAN,R.CHEN,Y.WANG, JRNL AUTH 6 D.E.SHAW,J.WATTERS,D.A.BERGSTROM JRNL TITL DISCOVERY OF LIRAFUGRATINIB (RLY-4008), A HIGHLY SELECTIVE JRNL TITL 2 IRREVERSIBLE SMALL-MOLECULE INHIBITOR OF FGFR2. JRNL REF PROC.NATL.ACAD.SCI.USA V. 121 56121 2024 JRNL REFN ESSN 1091-6490 JRNL PMID 38300868 JRNL DOI 10.1073/PNAS.2317756121 REMARK 2 REMARK 2 RESOLUTION. 3.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.11 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 10959 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.269 REMARK 3 R VALUE (WORKING SET) : 0.268 REMARK 3 FREE R VALUE : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 540 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 52.1100 - 5.2800 1.00 2727 128 0.2499 0.2591 REMARK 3 2 5.2800 - 4.1900 1.00 2592 139 0.2525 0.2852 REMARK 3 3 4.1900 - 3.6600 1.00 2566 128 0.2709 0.2866 REMARK 3 4 3.6600 - 3.3300 0.99 2534 145 0.3320 0.4002 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.454 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.109 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 69.68 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.22 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4515 REMARK 3 ANGLE : 0.709 6101 REMARK 3 CHIRALITY : 0.041 661 REMARK 3 PLANARITY : 0.018 771 REMARK 3 DIHEDRAL : 5.808 592 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8U1F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1000277093. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-MAY-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 17-ID-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14247 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.060 REMARK 200 RESOLUTION RANGE LOW (A) : 52.110 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.13600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.06 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.14 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS PH 8, 18% PEG K, PH 7, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.25650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.56600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.14000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.56600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.25650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.14000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 453 REMARK 465 HIS A 454 REMARK 465 MET A 455 REMARK 465 GLY A 456 REMARK 465 SER A 457 REMARK 465 PRO A 458 REMARK 465 MET A 459 REMARK 465 GLY A 583 REMARK 465 MET A 584 REMARK 465 GLU A 585 REMARK 465 TYR A 586 REMARK 465 SER A 587 REMARK 465 TYR A 588 REMARK 465 ASP A 589 REMARK 465 ILE A 590 REMARK 465 ASN A 591 REMARK 465 ARG A 592 REMARK 465 VAL A 593 REMARK 465 PRO A 594 REMARK 465 LEU A 647 REMARK 465 ALA A 648 REMARK 465 ARG A 649 REMARK 465 ASP A 650 REMARK 465 ILE A 651 REMARK 465 ASN A 652 REMARK 465 ASN A 653 REMARK 465 ILE A 654 REMARK 465 ASP A 655 REMARK 465 TYR A 656 REMARK 465 TYR A 657 REMARK 465 LYS A 658 REMARK 465 LYS A 659 REMARK 465 THR A 660 REMARK 465 THR A 661 REMARK 465 ASN A 662 REMARK 465 GLY A 663 REMARK 465 THR A 765 REMARK 465 ASN A 766 REMARK 465 GLU A 767 REMARK 465 GLU A 768 REMARK 465 SER B 453 REMARK 465 HIS B 454 REMARK 465 MET B 455 REMARK 465 GLY B 456 REMARK 465 SER B 457 REMARK 465 PRO B 458 REMARK 465 MET B 459 REMARK 465 LEU B 460 REMARK 465 ALA B 461 REMARK 465 GLY B 462 REMARK 465 VAL B 463 REMARK 465 SER B 464 REMARK 465 GLU B 465 REMARK 465 TYR B 466 REMARK 465 GLU B 467 REMARK 465 LEU B 468 REMARK 465 PRO B 469 REMARK 465 GLU B 470 REMARK 465 ASP B 471 REMARK 465 GLY B 583 REMARK 465 MET B 584 REMARK 465 GLU B 585 REMARK 465 TYR B 586 REMARK 465 SER B 587 REMARK 465 TYR B 588 REMARK 465 ASP B 589 REMARK 465 ILE B 590 REMARK 465 ASN B 591 REMARK 465 ARG B 592 REMARK 465 ARG B 649 REMARK 465 ASP B 650 REMARK 465 ILE B 651 REMARK 465 ASN B 652 REMARK 465 ASN B 653 REMARK 465 ILE B 654 REMARK 465 ASP B 655 REMARK 465 TYR B 656 REMARK 465 TYR B 657 REMARK 465 LYS B 658 REMARK 465 LYS B 659 REMARK 465 THR B 660 REMARK 465 THR B 661 REMARK 465 ASN B 662 REMARK 465 GLY B 663 REMARK 465 ARG B 664 REMARK 465 ASN B 766 REMARK 465 GLU B 767 REMARK 465 GLU B 768 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 464 74.17 62.67 REMARK 500 TYR A 466 43.04 -147.88 REMARK 500 LYS A 505 -17.59 68.82 REMARK 500 LYS A 509 -16.19 69.72 REMARK 500 ASN A 546 45.58 -104.52 REMARK 500 ALA A 643 -167.23 -115.66 REMARK 500 ALA A 726 -73.31 -56.69 REMARK 500 LEU B 483 -70.01 -91.70 REMARK 500 GLU B 489 63.29 -104.06 REMARK 500 CYS B 491 157.66 50.35 REMARK 500 PHE B 492 -61.36 65.65 REMARK 500 ASN B 546 37.17 -97.85 REMARK 500 LYS B 621 64.03 -66.64 REMARK 500 PHE B 645 141.20 -174.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG B 737 0.27 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8SWE RELATED DB: PDB REMARK 900 BOUND TO REVERSIBLE INHIBITOR OF THE SAME CHEMICAL SERIES. REMARK 900 RELATED ID: 8STG RELATED DB: PDB REMARK 900 CLINICAL STAGE COMPOUND DBREF 8U1F A 458 768 UNP P21802 FGFR2_HUMAN 458 768 DBREF 8U1F B 458 768 UNP P21802 FGFR2_HUMAN 458 768 SEQADV 8U1F SER A 453 UNP P21802 EXPRESSION TAG SEQADV 8U1F HIS A 454 UNP P21802 EXPRESSION TAG SEQADV 8U1F MET A 455 UNP P21802 EXPRESSION TAG SEQADV 8U1F GLY A 456 UNP P21802 EXPRESSION TAG SEQADV 8U1F SER A 457 UNP P21802 EXPRESSION TAG SEQADV 8U1F SER B 453 UNP P21802 EXPRESSION TAG SEQADV 8U1F HIS B 454 UNP P21802 EXPRESSION TAG SEQADV 8U1F MET B 455 UNP P21802 EXPRESSION TAG SEQADV 8U1F GLY B 456 UNP P21802 EXPRESSION TAG SEQADV 8U1F SER B 457 UNP P21802 EXPRESSION TAG SEQRES 1 A 316 SER HIS MET GLY SER PRO MET LEU ALA GLY VAL SER GLU SEQRES 2 A 316 TYR GLU LEU PRO GLU ASP PRO LYS TRP GLU PHE PRO ARG SEQRES 3 A 316 ASP LYS LEU THR LEU GLY LYS PRO LEU GLY GLU GLY CYS SEQRES 4 A 316 PHE GLY GLN VAL VAL MET ALA GLU ALA VAL GLY ILE ASP SEQRES 5 A 316 LYS ASP LYS PRO LYS GLU ALA VAL THR VAL ALA VAL LYS SEQRES 6 A 316 MET LEU LYS ASP ASP ALA THR GLU LYS ASP LEU SER ASP SEQRES 7 A 316 LEU VAL SER GLU MET GLU MET MET LYS MET ILE GLY LYS SEQRES 8 A 316 HIS LYS ASN ILE ILE ASN LEU LEU GLY ALA CYS THR GLN SEQRES 9 A 316 ASP GLY PRO LEU TYR VAL ILE VAL GLU TYR ALA SER LYS SEQRES 10 A 316 GLY ASN LEU ARG GLU TYR LEU ARG ALA ARG ARG PRO PRO SEQRES 11 A 316 GLY MET GLU TYR SER TYR ASP ILE ASN ARG VAL PRO GLU SEQRES 12 A 316 GLU GLN MET THR PHE LYS ASP LEU VAL SER CYS THR TYR SEQRES 13 A 316 GLN LEU ALA ARG GLY MET GLU TYR LEU ALA SER GLN LYS SEQRES 14 A 316 CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL SEQRES 15 A 316 THR GLU ASN ASN VAL MET LYS ILE ALA ASP PHE GLY LEU SEQRES 16 A 316 ALA ARG ASP ILE ASN ASN ILE ASP TYR TYR LYS LYS THR SEQRES 17 A 316 THR ASN GLY ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SEQRES 18 A 316 ALA LEU PHE ASP ARG VAL TYR THR HIS GLN SER ASP VAL SEQRES 19 A 316 TRP SER PHE GLY VAL LEU MET TRP GLU ILE PHE THR LEU SEQRES 20 A 316 GLY GLY SER PRO TYR PRO GLY ILE PRO VAL GLU GLU LEU SEQRES 21 A 316 PHE LYS LEU LEU LYS GLU GLY HIS ARG MET ASP LYS PRO SEQRES 22 A 316 ALA ASN CYS THR ASN GLU LEU TYR MET MET MET ARG ASP SEQRES 23 A 316 CYS TRP HIS ALA VAL PRO SER GLN ARG PRO THR PHE LYS SEQRES 24 A 316 GLN LEU VAL GLU ASP LEU ASP ARG ILE LEU THR LEU THR SEQRES 25 A 316 THR ASN GLU GLU SEQRES 1 B 316 SER HIS MET GLY SER PRO MET LEU ALA GLY VAL SER GLU SEQRES 2 B 316 TYR GLU LEU PRO GLU ASP PRO LYS TRP GLU PHE PRO ARG SEQRES 3 B 316 ASP LYS LEU THR LEU GLY LYS PRO LEU GLY GLU GLY CYS SEQRES 4 B 316 PHE GLY GLN VAL VAL MET ALA GLU ALA VAL GLY ILE ASP SEQRES 5 B 316 LYS ASP LYS PRO LYS GLU ALA VAL THR VAL ALA VAL LYS SEQRES 6 B 316 MET LEU LYS ASP ASP ALA THR GLU LYS ASP LEU SER ASP SEQRES 7 B 316 LEU VAL SER GLU MET GLU MET MET LYS MET ILE GLY LYS SEQRES 8 B 316 HIS LYS ASN ILE ILE ASN LEU LEU GLY ALA CYS THR GLN SEQRES 9 B 316 ASP GLY PRO LEU TYR VAL ILE VAL GLU TYR ALA SER LYS SEQRES 10 B 316 GLY ASN LEU ARG GLU TYR LEU ARG ALA ARG ARG PRO PRO SEQRES 11 B 316 GLY MET GLU TYR SER TYR ASP ILE ASN ARG VAL PRO GLU SEQRES 12 B 316 GLU GLN MET THR PHE LYS ASP LEU VAL SER CYS THR TYR SEQRES 13 B 316 GLN LEU ALA ARG GLY MET GLU TYR LEU ALA SER GLN LYS SEQRES 14 B 316 CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL SEQRES 15 B 316 THR GLU ASN ASN VAL MET LYS ILE ALA ASP PHE GLY LEU SEQRES 16 B 316 ALA ARG ASP ILE ASN ASN ILE ASP TYR TYR LYS LYS THR SEQRES 17 B 316 THR ASN GLY ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SEQRES 18 B 316 ALA LEU PHE ASP ARG VAL TYR THR HIS GLN SER ASP VAL SEQRES 19 B 316 TRP SER PHE GLY VAL LEU MET TRP GLU ILE PHE THR LEU SEQRES 20 B 316 GLY GLY SER PRO TYR PRO GLY ILE PRO VAL GLU GLU LEU SEQRES 21 B 316 PHE LYS LEU LEU LYS GLU GLY HIS ARG MET ASP LYS PRO SEQRES 22 B 316 ALA ASN CYS THR ASN GLU LEU TYR MET MET MET ARG ASP SEQRES 23 B 316 CYS TRP HIS ALA VAL PRO SER GLN ARG PRO THR PHE LYS SEQRES 24 B 316 GLN LEU VAL GLU ASP LEU ASP ARG ILE LEU THR LEU THR SEQRES 25 B 316 THR ASN GLU GLU HET GOL A 801 14 HET UIM A 802 63 HET SO4 B 801 5 HET UIM B 802 63 HETNAM GOL GLYCEROL HETNAM UIM N-[4-(4-AMINO-7-METHYL-5-{4-[(4-METHYLPYRIMIDIN-2-YL) HETNAM 2 UIM OXY]PHENYL}-7H-PYRROLO[2,3-D]PYRIMIDIN-6-YL)PHENYL]-2- HETNAM 3 UIM METHYLPROPANAMIDE HETNAM SO4 SULFATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL C3 H8 O3 FORMUL 4 UIM 2(C28 H27 N7 O2) FORMUL 5 SO4 O4 S 2- HELIX 1 AA1 PRO A 477 LEU A 481 5 5 HELIX 2 AA2 THR A 524 GLY A 542 1 19 HELIX 3 AA3 LEU A 572 ARG A 579 1 8 HELIX 4 AA4 THR A 599 GLN A 620 1 22 HELIX 5 AA5 ALA A 628 ARG A 630 5 3 HELIX 6 AA6 ALA A 671 ASP A 677 1 7 HELIX 7 AA7 THR A 681 THR A 698 1 18 HELIX 8 AA8 PRO A 708 GLU A 718 1 11 HELIX 9 AA9 THR A 729 TRP A 740 1 12 HELIX 10 AB1 VAL A 743 ARG A 747 5 5 HELIX 11 AB2 THR A 749 LEU A 763 1 15 HELIX 12 AB3 PRO B 477 LEU B 481 5 5 HELIX 13 AB4 THR B 524 GLY B 542 1 19 HELIX 14 AB5 ASN B 571 ALA B 578 1 8 HELIX 15 AB6 THR B 599 GLN B 620 1 22 HELIX 16 AB7 PRO B 666 MET B 670 5 5 HELIX 17 AB8 ALA B 671 PHE B 676 1 6 HELIX 18 AB9 THR B 681 THR B 698 1 18 HELIX 19 AC1 PRO B 708 GLU B 718 1 11 HELIX 20 AC2 THR B 729 TRP B 740 1 12 HELIX 21 AC3 VAL B 743 ARG B 747 5 5 HELIX 22 AC4 THR B 749 THR B 762 1 14 SHEET 1 AA1 5 LEU A 483 PRO A 486 0 SHEET 2 AA1 5 GLN A 494 VAL A 501 -1 O MET A 497 N GLY A 484 SHEET 3 AA1 5 ALA A 511 MET A 518 -1 O VAL A 516 N VAL A 496 SHEET 4 AA1 5 TYR A 561 GLU A 565 -1 O VAL A 564 N ALA A 515 SHEET 5 AA1 5 LEU A 550 CYS A 554 -1 N CYS A 554 O TYR A 561 SHEET 1 AA2 3 LYS A 569 ASN A 571 0 SHEET 2 AA2 3 VAL A 632 VAL A 634 -1 O VAL A 634 N LYS A 569 SHEET 3 AA2 3 MET A 640 ILE A 642 -1 O LYS A 641 N LEU A 633 SHEET 1 AA3 4 GLN B 494 VAL B 501 0 SHEET 2 AA3 4 ALA B 511 MET B 518 -1 O VAL B 516 N VAL B 496 SHEET 3 AA3 4 TYR B 561 VAL B 564 -1 O VAL B 564 N ALA B 515 SHEET 4 AA3 4 LEU B 550 CYS B 554 -1 N CYS B 554 O TYR B 561 SHEET 1 AA4 2 VAL B 632 VAL B 634 0 SHEET 2 AA4 2 MET B 640 ILE B 642 -1 O LYS B 641 N LEU B 633 LINK SG CYS A 491 C01 UIM A 802 1555 1555 1.89 LINK SG CYS B 491 C01 UIM B 802 1555 1555 1.89 CRYST1 62.513 88.280 129.132 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015997 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011328 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007744 0.00000